Comment on These glasses solve many central-vision problems. For $5000.
neo2478@sh.itjust.works 1 day agoThis seems like a US problem not a device problem.
Comment on These glasses solve many central-vision problems. For $5000.
neo2478@sh.itjust.works 1 day agoThis seems like a US problem not a device problem.
squaresinger@lemmy.world 1 day ago
Tbh, no. The device is realistically priced for a niche medical device with low number of units sold. Medical certification alone is around €500k. Development costs for a very custom device like this are also quite high. The price point isn’t crazy at all.
At the same time, health insurances (even more so here in Europe than in the US) are pretty slow to pay for new technology, especially if the benefit isn’t immediately tangible.
As in, “Will this reduce the need for further insurance spending by e.g. preventing hospital visits?” or “Will this allow a person who is on disability benefits to return to work?”